Indivior Pharmaceuticals, Inc.
INDV stock score: 65/100
$34.79 · +0.06% · Scored Oct 21, 2026
- Technical
- 58
- Fundamental
- 73
- News
- —
The reading
Indivior Pharmaceuticals (INDV) scores 65 out of 100, which reads neutral, higher than 95% of Healthcare stocks and 90% of the 4,166 US stocks we score.
The composite is technicals and fundamentals weighted equally: technicals read 58, fundamentals 73.
Among the fundamentals, Return on Invested Capital (ROIC) at 100 and Price Target at 100 score highest, while Free Cash Flow Yield at 5 weighs the most against it.
On the daily chart, trend-following indicators average 43 and contrarian oscillators 56.
Since Jul 25, 2026 the composite has ranged from 61 to 79, and it is down 14 points over the period.
What’s driving the score
The strongest and weakest of the scorers that count toward INDV’s composite. Each returns 0–100, higher is more bullish — including metrics where low is good, like P/E.
Fundamental
73Pulling it up
- Return on Invested Capital (ROIC)100
Return on Invested Capital measures the operating profit a company earns on all the capital invested in it, debt and equity alike.
- Price Target100
Price target score compares the current stock price to analyst consensus targets.
- Earnings Growth (Quarterly)100
Quarterly earnings growth measures profit increase versus the prior-year quarter.
Holding it back
- Free Cash Flow Yield5
Free cash flow yield is free cash flow divided by market value: the cash a business generates for each dollar of its price.
- Quick Ratio27
Quick ratio measures a company's ability to meet short-term obligations with liquid assets.
- Inventory Turnover28
Inventory turnover is how many times a year a company sells through its inventory.
36 weighted scorers; 5 had no data today and are left out rather than counted as zero.
Technical · daily
44Pulling it up
- 52-Week Change90
The price change over the last 52 weeks.
- SMA 586
Simple Moving Average (5-period) tracks the average price over the last 5 periods.
- Stoch RSI (14)81
Stochastic RSI combines Stochastic and RSI indicators for enhanced sensitivity to overbought/oversold conditions.
Holding it back
- Parabolic SAR (PSAR)0
Parabolic SAR (Stop and Reverse) provides trailing stop levels that follow price trends.
- SMA 100 Cross Up7
SMA 100 Cross Up identifies when shorter averages cross above the 100-period SMA.
- SMA 10012
Simple Moving Average (100-period) provides a longer-term perspective on price trends.
62 weighted scorers; 3 had no data today and are left out rather than counted as zero.
Technical score by timeframe
| Chart | Score | Weight |
|---|---|---|
| Hourly | 56 | 1 |
| Daily | 44 | 3 |
| Weekly | 56 | 2 |
| Monthly | 68 | 2 |
| Quarterly | 71 | 2 |
Composite score, last 90 days
Show the daily numbers
| Date | Composite |
|---|---|
| Oct 21, 2026 | 65 |
| Oct 20, 2026 | 65 |
| Oct 19, 2026 | 63 |
| Oct 18, 2026 | 61 |
| Oct 17, 2026 | 61 |
| Oct 16, 2026 | 61 |
| Oct 15, 2026 | 62 |
| Oct 14, 2026 | 63 |
| Oct 13, 2026 | 66 |
| Oct 12, 2026 | 68 |
| Oct 11, 2026 | 67 |
| Oct 10, 2026 | 67 |
| Oct 9, 2026 | 67 |
| Oct 8, 2026 | 66 |
| Oct 7, 2026 | 68 |
| Oct 6, 2026 | 67 |
| Oct 5, 2026 | 68 |
| Oct 4, 2026 | 67 |
| Oct 3, 2026 | 67 |
| Oct 2, 2026 | 67 |
| Oct 1, 2026 | 66 |
| Sep 30, 2026 | 65 |
| Sep 29, 2026 | 69 |
| Sep 28, 2026 | 69 |
| Sep 27, 2026 | 68 |
| Sep 26, 2026 | 69 |
| Sep 25, 2026 | 67 |
| Sep 24, 2026 | 69 |
| Sep 23, 2026 | 68 |
| Sep 22, 2026 | 68 |
| Sep 21, 2026 | 67 |
| Sep 20, 2026 | 66 |
| Sep 19, 2026 | 66 |
| Sep 18, 2026 | 66 |
| Sep 17, 2026 | 67 |
| Sep 16, 2026 | 64 |
| Sep 15, 2026 | 64 |
| Sep 14, 2026 | 64 |
| Sep 13, 2026 | 65 |
| Sep 12, 2026 | 65 |
| Sep 11, 2026 | 65 |
| Sep 10, 2026 | 64 |
| Sep 9, 2026 | 63 |
| Sep 8, 2026 | 65 |
| Sep 7, 2026 | 65 |
| Sep 6, 2026 | 65 |
| Sep 5, 2026 | 65 |
| Sep 4, 2026 | 65 |
| Sep 3, 2026 | 66 |
| Sep 2, 2026 | 66 |
| Sep 1, 2026 | 67 |
| Aug 31, 2026 | 64 |
| Aug 30, 2026 | 65 |
| Aug 29, 2026 | 65 |
| Aug 28, 2026 | 64 |
| Aug 27, 2026 | 65 |
| Aug 26, 2026 | 67 |
| Aug 25, 2026 | 65 |
| Aug 24, 2026 | 66 |
| Aug 23, 2026 | 66 |
| Aug 22, 2026 | 67 |
| Aug 20, 2026 | 69 |
| Aug 19, 2026 | 72 |
| Aug 18, 2026 | 71 |
| Aug 17, 2026 | 70 |
| Aug 16, 2026 | 69 |
| Aug 15, 2026 | 69 |
| Aug 14, 2026 | 69 |
| Aug 13, 2026 | 68 |
| Aug 12, 2026 | 70 |
| Aug 11, 2026 | 70 |
| Aug 10, 2026 | 70 |
| Aug 9, 2026 | 70 |
| Aug 8, 2026 | 70 |
| Aug 7, 2026 | 69 |
| Aug 6, 2026 | 65 |
| Aug 5, 2026 | 64 |
| Aug 3, 2026 | 64 |
| Aug 2, 2026 | 69 |
| Jul 31, 2026 | 72 |
| Jul 30, 2026 | 72 |
| Jul 29, 2026 | 71 |
| Jul 28, 2026 | 79 |
| Jul 27, 2026 | 78 |
| Jul 26, 2026 | 79 |
| Jul 25, 2026 | 79 |
Key facts
- Market cap
- $4.1B
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Beta
- 1.18
- Risk grade (1–10)
- 3
- Next earnings
- Oct 29, 2026
Drug Manufacturers - Specialty & Generic peers
| Company | Market cap | Score |
|---|---|---|
| LNTH Lantheus | $6.5B | 66 |
| KNSA Kiniksa Pharmaceuticals International | $6.2B | 65 |
| RGC Regencell Bioscience Holdings | $5.4B | 38 |
| AMLX Amylyx Pharmaceuticals | $3.6B | 54 |
| LQDA Liquidia | $3.5B | 56 |
| HCM HUTCHMED (China) | $2.5B | 55 |
Questions
What is INDV's stock score today?
INDV scores 65/100 (Neutral) as of Oct 21, 2026: technical 58, fundamental 73. Scores are recomputed every night.
Is INDV a buy?
The score is not a buy or sell recommendation. A 65 says the technical and fundamental signals we measure lean neutral today, relative to every other stock scored the same way. Use the breakdown above to see why, and treat it as a starting point for your own research.
How is the INDV score calculated?
98 weighted scorers feed it today: 36 fundamental, scored against Healthcare ranges, and 62 technical on the daily chart, with 5 timeframes blended into the technical total. Every scorer returns 0–100; missing data is left out, never counted as zero.
Scores are information, not investment advice. Computed from Yahoo Finance, Finnhub and Alpha Vantage data; technical indicators via TA-Lib. Past scores do not predict future returns.